KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Cash from Financing Activities (2016 - 2025)

Cme (CME) has disclosed Cash from Financing Activities for 17 consecutive years, with $9.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 1105.91% to $9.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $56.5 billion, a 1013.16% increase, with the full-year FY2025 number at $56.5 billion, up 1013.16% from a year prior.
  • Cash from Financing Activities was $9.9 billion for Q4 2025 at Cme, up from $6.4 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $35.4 billion in Q1 2021 to a low of -$29.7 billion in Q2 2022.
  • A 5-year average of $2.9 billion and a median of $4.5 billion in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 4528.82% in 2021, then crashed 2380.44% in 2023.
  • Cme's Cash from Financing Activities stood at $9.4 billion in 2021, then tumbled by 154.19% to -$5.1 billion in 2022, then soared by 150.84% to $2.6 billion in 2023, then tumbled by 138.02% to -$984.1 million in 2024, then surged by 1105.91% to $9.9 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Cash from Financing Activities are $9.9 billion (Q4 2025), $6.4 billion (Q3 2025), and $21.0 billion (Q2 2025).